Equities

Sensus Healthcare Inc

Sensus Healthcare Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)5.96
  • Today's Change0.015 / 0.25%
  • Shares traded170.68k
  • 1 Year change+101.86%
  • Beta1.0370
Data delayed at least 15 minutes, as of May 22 2024 17:36 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.

  • Revenue in USD (TTM)31.66m
  • Net income in USD4.65m
  • Incorporated2010
  • Employees35.00
  • Location
    Sensus Healthcare Inc851 Broken Sound Pkwy NW Ste 215BOCA RATON 33487-3635United StatesUSA
  • Phone+1 (561) 922-5808
  • Fax+1 (561) 948-2071
  • Websitehttps://sensushealthcare.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
DIH Holding US Inc60.30m-1.77m64.47m--------1.07-0.0435-0.04351.49-0.8079----------------60.18---2.93--0.26561.50----12.15--80.41------
Pro-Dex Inc48.24m5.00m65.49m146.0013.772.1310.831.361.391.3913.448.980.97462.303.68330,438.3010.1115.4312.9418.8728.2533.1510.3714.922.16--0.27530.009.6215.4654.7232.380.8422--
Vivos Inc18.00k-3.20m66.13m10.00--49.29--3,673.92-0.0087-0.00870.000050.00340.0127--3.13---225.38-202.25-235.64-552.77-33.3310.79-17,805.45-11,969.07----0.00---46.58---17.19------
Asensus Surgical Inc8.72m-78.71m67.54m207.00--5.18--7.74-0.3065-0.30650.03390.04790.12711.7913.0942,144.93-114.63-71.10-146.89-79.04-52.04-71.39-902.25-1,207.710.689--0.00--21.02-18.67-3.80---6.14--
Neuronetics Inc73.23m-27.54m73.19m202.00--2.64--0.9996-0.9484-0.94842.520.92260.70612.265.43360,714.30-26.56-28.02-30.98-34.7375.5275.73-37.61-51.045.18-4.270.6825--9.426.2218.76--18.57--
T2 Biosystems Inc7.18m-45.65m83.75m113.00------11.67-17.91-17.912.21-6.850.24973.244.9363,504.43-158.80-106.01---253.03-116.97-12.60-636.09-317.930.1936--10.70---67.75-7.2919.66---20.19--
Fonar Corp102.72m10.29m96.69m561.009.730.58345.130.94131.481.4814.7224.700.502319.991.41183,098.207.168.737.409.6045.5548.3314.2616.399.16--0.0051--1.083.89-24.71-15.058.48--
Sensus Healthcare Inc31.66m4.65m97.37m35.0020.841.9019.773.080.28510.28511.943.120.57211.021.96904,428.608.4110.299.4012.1460.3462.8514.7015.296.49--0.00---45.20-1.58-98.00---23.16--
KORU Medical Systems Inc29.32m-13.27m97.48m82.00--5.09--3.32-0.2905-0.29050.64220.41810.89192.386.85357,595.80-40.35-17.60-47.06-20.2960.2459.44-45.24-21.703.37--0.0284--2.2310.44-58.65--11.10--
Xtant Medical Holdings Inc101.23m-1.66m98.12m207.00--2.0647.960.9692-0.0189-0.01890.80190.36621.291.366.06489,043.50-2.11-10.38-2.98-14.6861.4761.08-1.64-8.660.978-4.140.3638--57.504.81107.78--18.47--
Vivani Medical Inc0.00-25.37m98.14m44.00--3.42-----0.4954-0.49540.000.52220.00----0.00-51.59-56.58-58.76-67.66-------2,868.72----0.00-------84.69--40.33--
Vuzix Corp9.94m-49.96m99.68m94.00--1.36--10.03-0.7826-0.78260.15581.130.09971.302.52105,762.30-50.09-41.61-54.56-44.80-35.85-6.13-502.49-317.286.57--0.00--2.488.42-23.02--39.42--
Myomo Inc19.55m-9.34m111.22m101.00--10.20--5.69-0.2676-0.26760.57750.37861.293.2312.10193,552.80-61.73-81.78-89.94-115.2767.3968.50-47.77-85.762.40--0.00--23.7051.0924.00--2.82--
Akso Health Group - ADR2.20m-17.07m126.16m12.00------57.28-0.7466-0.24610.0963--0.11661.910.3202183,560.00-89.84-17.36-224.28-23.997.56---770.59-256.641.36-24.020.6531--119.69-34.25-221.68------
Akoya Biosciences Inc93.57m-68.01m130.38m330.00--3.98--1.39-1.47-1.471.990.66320.60562.207.08283,554.50-44.01---56.06--55.99---72.68--2.38-10.150.7013--29.09--10.36------
Data as of May 22 2024. Currency figures normalised to Sensus Healthcare Inc's reporting currency: US Dollar USD

Institutional shareholders

11.18%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 2024774.09k4.72%
Renaissance Technologies LLCas of 31 Mar 2024291.24k1.78%
Perritt Capital Management, Inc.as of 31 Mar 2024130.59k0.80%
Geode Capital Management LLCas of 31 Mar 2024127.62k0.78%
Newton Investment Management North America LLCas of 31 Mar 2024123.37k0.75%
Sachetta LLCas of 31 Mar 2024104.81k0.64%
Two Sigma Advisers LPas of 31 Mar 202480.70k0.49%
Dimensional Fund Advisors LPas of 31 Mar 202473.08k0.45%
Millennium Management LLCas of 31 Mar 202466.23k0.40%
BlackRock Fund Advisorsas of 31 Mar 202461.21k0.37%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.